Static Chart Aldeyra Therapeutics, Inc.

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-14 pm EDT			5-day change	1st Jan Change
4.17 ^USD	+12.70%		0.00%	+18.80%

May. 08	Aldeyra Therapeutics Enrolls First Patient in Phase 3 Dry Eye Chamber Study	MT
May. 08	Aldeyra Therapeutics, Inc. Enrolls First Patient in Phase 3 Clinical Trial Designed to Enable Potential Resubmission of New Drug Application of Reproxalap in Dry Eye Disease	CI

Duration

Period